PD‐1 inhibitors (pembrolizumab, nivolumab, and retifanlimab) or PD‐L1 inhibitors (avelumab) have shown efficacy in disseminated MCC in prospective clinical trials [49]. Here, CD274 is linked to Merkel cell skin cancer.